Noncolorectal Gastrointestinal Cancer Journal Articles

• Regular Use of PPI and Risk of Rheumatoid Arthritis in Women Might alteration of the gut microbiome by regular use of protein pump inhibitors increase the risk of rheumatoid arthritis in women?
  Alimentary Pharmacology & Therapeutics, August 05, 2020
• SVR From DAA, Interferon-based Treatments for HCV and HCC Risk How does sustained virologic response from direct-acting antiviral and interferon-based treatments impact the risk of developing hepatocellular carcinoma?
  Journal of Viral Hepatitis, August 05, 2020
• HCV Co-Infection and Treatment and CKD Risk in HIV Might HCV treatment have a role in mitigating the risk for developing chronic kidney disease among HIV/HCV co-infected individuals?
  AIDS, August 05, 2020
• Response of Brain Mets From PIK3CA-Mutant BC to Alpelisib Is the newly approved PI3K-inhibitor alpelisib a safe and effective option for breast cancer patients with brain metastases? A case series provides insight into the treatment response.
  JCO Precision Oncology, July 30, 2020
• Barriers to Hepatitis C Screening and Linkage to Care This study aimed to identify patient and provider barriers that contribute to suboptimal HCV screening and linkage-to-care. What opportunities exist to improve HCV screening and treatment delivery?
  Journal of Viral Hepatitis, July 24, 2020
• New Insights in the Management of Hepatocellular Adenoma While benign, hepatocellular adenoma may be complicated by hemorrhage or malignant transformation to HCC. Review the latest on its epidemiology, diagnosis, prognosis and treatment in this article.
  Liver International, July 24, 2020
• Safe Cholecystectomy Practice Guideline and Consensus This article provides evidenced-based, consensus recommendations for safe cholecystectomy and prevention of bile duct injury.
  Annals of Surgery, July 21, 2020
• Linkage to and Retention in Care Among Refugees With HBV This report assessed a quality improvement intervention and outreach program for refugees with hepatitis B infection at three U.S. refugee screening sites.
  Morbidity & Mortality Weekly Report, July 20, 2020
• COVID-19 and Liver Disease--What We Know This review summarizes changes in liver function observed during SARS-CoV-2 infection. What impact does COVID-19 have on patients with underlying chronic liver disease?
  Alimentary Pharmacology & Therapeutics, July 20, 2020
• HCC in Chronic HCV Patients Who Achieved SVR Does achieving SVR with DAAs reduce the incidence of hepatocellular carcinoma in chronic hepatitis C patients, genotype IV with liver cirrhosis and advanced hepatic fibrosis?
  Journal of Viral Hepatitis, July 17, 2020
• Periodontitis and All-cause and Cancer Mortality How does periodontitis impact mortality? This study assessed the association between periodontitis and all-cause mortality, all-cancer and specific cancers' mortality in elderly persons.
  BMC Oral Health, July 16, 2020
• Sequential Systemic Treatment in Patients With HCC This study investigated the feasibility and efficacy of sequential systemic treatments with currently available and recently approved drugs for the treatment of hepatocellular carcinoma.
  Alimentary Pharmacology & Therapeutics, July 13, 2020
• RCTs Towards a Single-visit Cure for Chronic Hepatitis C This study evaluated the safety and feasibility of a single-visit cure for chronic hepatitis C using a combination of two novel agents.
  Journal of Viral Hepatitis, July 10, 2020
• Clinical Application of Metabolomics in Pancreatic Diseases Can metabolomics provide a more efficient and sensitive diagnostic method for pancreatic disease? This review explores the potential of metabolomics in early detection, diagnosis, and identification.
  Laboratory Medicine, July 08, 2020
• Inflammatory Bowel Disease and Pancreatic Cancer Do patients with IBD have a significantly increased risk of pancreatic cancer?
  Alimentary Pharmacology & Therapeutics, July 06, 2020
• Tamoxifen-related NAFLD: Prevalence, Incidence, Risk Factors How common is the development of fatty liver after tamoxifen treatment in breast cancer patients, and what are the associated risk factors?
  Liver International, July 03, 2020
• COVID-19 Prevention, Diagnosis, Management in the IBD Patient Since many IBD therapies may weaken the immune system and increase infection risk, IBD patient management presents a challenge during the current COVID-19 pandemic.
  Alimentary Pharmacology & Therapeutics, July 01, 2020
• NAFLD Progression Rates to Cirrhosis, Decompensation, Mortality This study aimed to elucidate the natural history of NAFLD/NASH by evaluating the impact of liver disease severity and comorbid health conditions on risk of mortality and risk of disease progression.
  Alimentary Pharmacology & Therapeutics, June 22, 2020
• HCV Resistance-associated Substitutions in Failed DAA Therapy This study aimed to quantify and characterize resistance-associated substitutions in HCV patients refractory to direct-acting antiviral treatment.
  Journal of Viral Hepatitis, June 17, 2020
• HCV Relapse After Successful Treatment With DAAs HCV recurred in this patient 6 months after achieving SVR with direct-acting antiviral therapy, along with a sarcomatous change in HCC. What might be the relationship between these events?
  Journal of Medical Case Reports, June 15, 2020